Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase III trial of TV1001SR in the patients with systemic sclerosis

Trial Profile

Phase III trial of TV1001SR in the patients with systemic sclerosis

Planning
Phase of Trial: Phase III

Latest Information Update: 13 Jun 2017

At a glance

  • Drugs Sodium nitrite (Primary)
  • Indications Systemic scleroderma
  • Focus Registrational; Therapeutic Use
  • Sponsors Soin Neuroscience
  • Most Recent Events

    • 13 Jun 2017 New trial record
    • 07 Jun 2017 According to a Soin Neuroscience media release, this trial is expected to begin within the next year.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top